Clinical Trial Follow-up Confirms Discontinuation of Intensive Blood Glucose Control Results in Reversal of A1c Improvement

ATLANTA, GA -- (Marketwire) -- 07/28/11 -- ALR Technologies Inc. (OTCBB: ALRT) announces follow-up results of…

Continue Reading